Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
  • 首页
The 10th Asia Pharma R&D Leaders 2020

The 10th Asia Pharma R&D Leaders

Time: Aug. 26th-27th, 2020

Address: Beijing · China

Topic: Do Not Forget Why We Started. For Drug Innovation in the Next Decade!

The 10th Asia Pharma R&D Leaders Summit is one of the high-level strategic summits in the field of pharmaceutical R&D in Asia. This conference will gather together experts and senior executives from Chinese pharma companies, biotechnology companies, multinational pharmaceutical companies, research institutes and other companies, who are persisting in fighting for patients’ health on the front line of new drug R&D, discussing the status and trends of new drug R&D, exploring on strategy innovation and changes of drug development, clinical R&D and decision-making. 

Conference Overview

【Event Background】

The 10th Asia Pharma R&D Leaders Summit is one of the high-level strategic summits in the field of pharmaceutical R&D in Asia. This conference will gather together experts and senior executives from Chinese pharma companies, biotechnology companies, multinational pharmaceutical companies, research institutes and other companies, who are persisting in fighting for patients’ health on the front line of new drug R&D, discussing the status and trends of new drug R&D, exploring on strategy innovation and changes of drug development, clinical R&D and decision-making. This event is aiming at providing a broad platform for corporations and improving the progress of Asian medicine. It could help in promoting the implementation of policies and regulations, optimizing drug development strategy decisions, grasping research and development trends, deepening internal innovation and external cooperation, stepping towards the international arena.

The two-day conference is divided into one-day plenary session and one-day parallel forums. The panel discussion, keynote speech, biotechnology showcases, roundtable discussion for all and one-on-one meeting will take you into the perspective of pharmaceutical R&D leaders and display a wonderful feast for the mind.


【Key Issues】

> Converge pharmaceutical R&D leaders and experts, share the latest drug development breakthroughs.

> Deeply analyze the latest medical reform policy system, comprehensively interpret the ecological environment of pharmaceutical R&D.

> Focus on the development of cutting-edge technology in the industry, grasp the trend of new drug development in the future.

> Explore a new model of R&D strategy layout, accelerate the optimization of drug development processes.

> Analyze clinical research problems and challenges, scientifically develop clinical development strategies, effectively reduce R&D risks, and improve R&D efficiency.

> Insight into new patterns of external cooperation and innovation, work in synergy together to accelerate drug development.

Who should attend】

The 10th Asia Pharma R&D Leaders 2020

【A Glance of Past Inspirational Speakers】

The 10th Asia Pharma R&D Leaders 2020

The 10th Asia Pharma R&D Leaders 2020

【Your Chances to Meet Part of Previous Attending Companies】

The 10th Asia Pharma R&D Leaders 2020

【Event Highlights】

The 10th Asia Pharma R&D Leaders 2020

【Wonderful Moment】

The 10th Asia Pharma R&D Leaders 2020

【Previous Summits】

The 10th Asia Pharma R&D Leaders 2020

Event Organizer

The 10th Asia Pharma R&D Leaders 2020

The 10th Asia Pharma R&D Leaders 2020
Conference Organizer / Co-Organizer

The 10th Asia Pharma R&D Leaders 2020

Guidance / co-sponsor / support
  • The Precision Medicine Professional Committee of Chinese Society of Biotechnology
  • MSQ
  • BayHelix
  • NDFC
  • Taiwan Bio
  • CBA
  • SAPA
  • Dr. Michael Chen Business Development Vice President Akeso,Inc.(9926.HK)
  • Sophie ZHAO Regional Marketing Manager - China 10x Genomics
  • Jianjun ZOU Chief Medical Officer, Vice president Jiangsu Hengrui Medicine Co.,Ltd.
  • James Yan Executive Vice President, Head of Early Developmen Zai Lab
  • Jason YANG Chief Medical Officer and Senior VP CStone Pharmaceuticals
  • Bing YUAN Chief Business Officer CStone Pharmaceuticals
  • Joan SHEN CEO I-Mab Biopharma Co., Ltd
  • Li Chen Founder and CEO,CSO Hua Medicine (Shanghai) Ltd.
  • Michelle XIA Chairman & CEO Akeso Biopharma Inc.
  • Yinxiang WANG Chairman & CEO Jacobio Pharmaceuticals Co., Ltd.
  • Ming GUO Co-Founder & COO Ascentage Pharma
  • Chengbin WU Founder & CEO EpimAb Biotherapeutics Inc.
  • Frank FAN Co-Founder & CSO Nanjing Legend Biotechnology Co., Ltd
  • Richard WANG CEO Fosun Kite Biotechnology Co., Ltd
  • Junjian LIU VP, Biologics Discovery Innovent Biologics (Suzhou) Co., Ltd
  • Jun BAO President & CEO Impact Therapeutics, Inc.
  • Grace ZHOU Co-Founder & CEO Immvira Co., Ltd.
  • Nick ZHANG Board Chairman and CEO QIAGEN (Suzhou) Translational Medicine Co., Ltd
  • Ye Hua Founder, Chairman and CEO BioNova Pharmaceuticals Ltd
  • Xiaoxiang CHEN Executive Vice President, Chief Development Office Harbour BioMed
  • Jian Peng SVP,Regulatory Affairs and Drug Development Strate Beijing Shenogen Pharma Group Ltd.
  • Li WANG SVP,  Drug Development and Medical Affairs Eli Lilly and Company (China)
  • Richard Nieman Vice President, Head of R&D China Bristol-Myers Squibb
  • Yong ZHANG General Manager of SOTIO China SOTIO
  • Johannes Nippgen Vice President, Head of R&D China Merck Group
  • Yuanhua DING Executive Director, Head of Pfizer External Scienc Pfizer
  • Ross Horsburgh Vice President, Head of Development JAPAC Region AbbVie
  • Joyce LI Vice President, China Medical Affairs Roche
  • Victoria Elegant Vice President, Region Head Medical Amgen
  • Annie YIN Vice President, Regulatory Affairs Johnson & Johnson Medical China
  • Xiangsheng YE Sr. Director Cancer Research Asia Lilly China R&D Co.,Ltd
  • Amy TANG Venture Partner Qiming Venture Partner
  • Anna ZHU Vice President, Global Issuer Services HKEX-Hong Kong Exchanges & Clearing Ltd.
  • SINOCRO Pharmaceutical Science Co., Ltd.
  • Burning Rock Biotech Limited
  • Haier Biomedical
  • Pfizer CentreOne
  • Quanterix Corporation
  • Accurant Biotech
  • Viva Biotech
  • Cyagen
  • Thermo Fisher Scientific Inc.
  • ​Almac Clinical Services
  • New England Biolabs
  • Beijing JingCheng Med-Pharma Service Co., Ltd
  • Canton Biologics
  • Beijing IDMO Co., Ltd.
  • Genome Wisdom (Beijing) Gene Technology Co., Ltd.
  • WuXi NextCODE
  • PPD
  • Chime Biologics
  • Almac
  • Chengdu Shengnuo Bio-Pharmaceutical Co., Ltd.
  • GCP ClinPlus Co., Ltd.
  • Shanghai Model Organisms Center, Inc.
  • Bio-Techne
  • EC Innovations
  • Wuhan Pudu Biomedical Co., Ltd.
  • Frontage
  • MabPlex International, LTD.
  • Nucleus Network
  • GenScript Biotech Corporation
  • Hangzhou Tigermed Consulting Co., Ltd
  • Laviana Pharma Co,. LTD.
  • Sphinx Scientific
  • Rapid Novor Inc
Cooperative Media
    发布时间: 2020 - 04 - 17
    Asia-Pacific Biotech News (APBN)
    发布时间: 2019 - 07 - 11
    Asia-Pacific Biotech News (APBN) is a monthly magazine published by World Scientific Publishing, one of the leading scientific publishers in the world. We cover topics in the areas of biotechnology, life sciences, healthcare, pharmaceutical, medical, food and agriculture, and as of the first half of 2019, online circulation numbers are ~10,000. APBN’s readership reaches out to various professionals in the field those of which include scientists, researchers, industry experts and biotech investors. The aim of APBN is to bring up – to date news and advancements in the science and technology field within the Asia – Pacific region.
    发布时间: 2020 - 04 - 17
    发布时间: 2020 - 04 - 17
    发布时间: 2020 - 04 - 09
    发布时间: 2019 - 07 - 11
    Lingmed is a young, professional and fast growing company, it promotes world best in class intelligence databases to healthcare industry and provide with its premium services – Linkedbio - which provides analytical services and reports to help our clients to make better decisions and support BD sourcing activities.
    Global Data
    发布时间: 2020 - 04 - 09
    Global Data
    发布时间: 2019 - 07 - 11
    Insight-China Pharma Data
    发布时间: 2019 - 07 - 11
    Insight-China Pharma Data, presented by DXY elite team, focusing on collect and analyse medical information and digging insight from vast data.We already have more than 80 thounsands corporate and individual customers, including pharma company, CRO, financial institutions, helping them with product registration, progress, results, patent, bidding, government regulation, industry news and professional consulting service.
    Pharmacodia (Beijing) Co., Ltd. (“Pharmacodia”)
    发布时间: 2019 - 07 - 11
    Founded in 2013, Pharmacodia (Beijing) Co., Ltd. (“Pharmacodia”) is China’s first pharmaceutical R&D big data company.  Pharmacodia has successfully created a comprehensive information service platform in the biomedicine field.  Based on in depth analysis of pharmaceutical R&D Data, the company provides service including database support, drug news, R&D resources.  Pharmacodia has become the 'Leader' of China's pharmaceutical information provider. Pharmacodia products have covered more than 140 countries and are widely used in government agencies, university research institutes, drug research and development companies, investment and financing institutions.  Pharmacodia was awarded 'ZHONGGUANCUN Pharmaceutical R&D Big-Data Platform&#...
    发布时间: 2019 - 07 - 11
    发布时间: 2019 - 10 - 31
    Found in June 2014, JPM.cn is a leading internet finance (ITFIN) company with a focus on digital media. JPM.cn is one of the cutting edge Chinese companies to raise capital by crowdfunding and to use crowdsourcing content. JPM.cn adopts a user-generated content platform. Our users include, but are not limited to, booming scholars, prominent experts, mainstream media financial journalists and C-level executives in the ITFIN field worldwide. By allowing the professional community to post editorials about ITFIN, users can benefit from having access to the opinions of experienced ITFIN professionals on matters such as industry outlook, trend development, industry updates, company profiles, policies and regulations. Currently, the number of daily unique visitors to JPM.cn consistently...
    发布时间: 2019 - 07 - 11
    发布时间: 2019 - 07 - 11
    Established since 1998, Bio-Equip is a leading website to provide the users in the fields of life science, medicine research, biological pharmacy, bio-engineering, modern agriculture and food safety with the industrial information in terms of devices and instruments, reagents, consumables, lab animals, cell lines, books, biological R&D service, second-hand instruments and instrument repairs.
    Chinese Journal of Biologicals
    发布时间: 2019 - 07 - 11
    Chinese Journal of Biologicals, hereinafter referred to as Journal, is under the leadership of Ministry of Health of the People's Republic of China and sponsored by China Preventive Medicine Association. It mainly reports information of China biologicals, important R&D achievements and latest progresses of biologicals,as well as the status of worldwide biological and biotechnology products. The main readers of it are production, research and management personnel who come from biological and biotechnology products enterprises, clinician, and government officials who take charge of verification, disease surveillance and control.Biologicals, which are used for the prevention, treatment and diagnose of human disease, are produced of microorganism, cell and animal or human tissue a...
    发布时间: 2019 - 07 - 17
    Rolled out in 2010, CPhI.CN (www.en-cphi.cn) is one of the most active vertical B2B online trade platform serving the pharmaceutical industry.As a trusted and reliable source of information, CPhI.cn boasts five sections covering products, suppliers, CAS Database, Events and News, generating unlimited business opportunities for the best suppliers and buyers from whole industry chain, and delivering business news and information for industry professionals every day.Whether your goals is product promotion, brand awareness, lead generation or industry news, CPhI.cn enables your branding and product messages to be delivered into the right hands, and ensures that up-to-date industry information reach you on time.
    发布时间: 2019 - 07 - 31
    Founded in Shanghai in 2002, GBI has built a diverse portfolio of market intelligence solutions for pharmaceutical and device companies and other service providers. Focused on China and the Latin American markets, GBI’s value-added industry information, news, and data services power individuals and organizations’ decision-making and enable more effective communication. As a trusted source of information, GBI has established long-term relationships with both multinational players and local firms, and continues to drive forward the health care industry.GBI has offices in Shanghai, Beijing, and Washington D.C.
    Sina Medicine
    发布时间: 2019 - 11 - 07
    Bearing the genes of “only high qualities come from Sina”, Sina Medicine is committed to becoming the best quality, the most authoritative and professional, and the most comprehensive information platform in pharmaceutical industry by specializing in the field of medicine, bringing together cutting-edge information, and taking advantage of Sina’s 10-million-level daily views. The platform launches website (med.sina.com), WeChat (sinayiyao), and micro-blog simultaneously to provide users with latest information like medical policies, researching trends, news of pharmaceutical companies, mobile medical industry, and industry insight in a comprehensive and accurate way, enabling users to take a 360-degree view of medicine on a 365-day basis.
Travel & Stay

For More Information, please contact us
Liz LI
T: +86 21 60957201